EQUITY RESEARCH MEMO

Vibrant America Clinical Laboratory

Generated 6/22/2026

Executive Summary

Conviction (model self-assessment)65/100

Vibrant America Clinical Laboratory is a privately held diagnostics company based in San Carlos, California, founded in 2017. The company operates a CLIA- and CAP-certified laboratory that offers a comprehensive menu of clinical tests, with a particular emphasis on autoimmune diagnostics. By leveraging multiplexing technology, Vibrant America aims to deliver efficient, affordable, and rapid test results to physicians, patients, and hospitals across all 50 states. The company's web-based reporting system further enhances accessibility and turnaround times, positioning it as a competitive player in the U.S. diagnostic testing market. Despite its niche focus on autoimmunity, the company serves a broad range of clinical needs and continues to expand its test offerings to meet evolving healthcare demands.

Upcoming Catalysts (preview)

  • Q3 2026Launch of expanded autoimmune panel70% success
  • Q4 2026Partnership with major health system for test distribution50% success
  • TBDFDA clearance for a novel diagnostic assay30% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)